Back to Search

INDERJIT MEHMI, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1801092705IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

01070849A(IN)
Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

24937(WV)

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Additional

INTERNAL MEDICINE

Education

OTHER

Class of 2007

Research & Publications (14)

Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
PMID 16847284·J Clin Oncol·2006
8-other
Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
PMID 15703820·Int J Oncol·2005
8-other
A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
PMID 15592521·Oncogene·2005
8-other
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
PMID 15390078·Mol Carcinog·2004
7-preclinical
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.
PMID 15235125·Proc Natl Acad Sci U S A·2004
8-other
Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
PMID 15138577·Int J Oncol·2004
8-other
Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
PMID 15094777·Oncogene·2004
8-other
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
PMID 14767544·Int J Oncol·2004
8-other
Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth.
PMID 14532983·Int J Oncol·2003
8-other
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.
PMID 12790776·Endocr Relat Cancer·2003
6-review
A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
PMID 12776196·Oncogene·2003
8-other
Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
PMID 12569369·Oncogene·2003
8-other
Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
PMID 12556556·Mol Cancer Res·2003
7-preclinical
Expression and regulation of Cyr61 in human breast cancer cell lines.
PMID 11840342·Oncogene·2002
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
11800 WILSHIRE BLVD FL 3
LOS ANGELES, CA 90025

Locations (2)

Practice Location

11800 WILSHIRE BLVD FL 3, LOS ANGELES, CA
(310) 231-2121

Practice Location

1 Medical Center Drive, Morgantown, WV
(304) 293-4229

Quick Facts

NPI
1801092705
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
19
Publications
14

Are you this provider?

Claim Your Profile